Is there a role for immune checkpoint inhibitors in selected rare subtypes of soft tissue sarcoma?

Tarek Assi, Axel Le Cesne, Olivier Mir

    Research output: Contribution to journalReview articlepeer-review

    1 Citation (Scopus)
    Original languageEnglish
    Pages (from-to)91-93
    Number of pages3
    JournalImmunotherapy
    Volume13
    Issue number2
    DOIs
    Publication statusPublished - 1 Feb 2021

    Keywords

    • cancer
    • checkpoint inhibitors
    • immunotherapy
    • pembrolizumab
    • rare
    • sarcoma

    Cite this